American International Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
ST
LCM
RG
BBA
RI
CAC
American International Group's STOK Position: Q2 2024 in Review
American International Group sold out of Stoke Therapeutics (STOK) in Q2 2024, closing a stake of 13,738 shares — an estimated $185K sold.
American International Group first reported a position in STOK in Q3 2019 and held it in 19 quarters. The position peaked at $266K in Q3 2021. 114 funds tracked by Wall St. Rank hold STOK as of Q2 2024.
- American International Group reported no remaining Stoke Therapeutics position as of Q2 2024 after selling out during the quarter.
- American International Group sold 13,738 Stoke Therapeutics shares in Q2 2024, an estimated $185K.
- American International Group first reported a position in Stoke Therapeutics in Q3 2019 and held it in 19 quarters.
- American International Group's Stoke Therapeutics position peaked at $266K in Q3 2021.
- 114 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.